|
Name |
gibberellin A12(2-)
|
Molecular Formula | C20H26O4-2 | |
IUPAC Name* |
(1R,2S,3S,4R,8S,9S,12R)-4,8-dimethyl-13-methylidenetetracyclo[10.2.1.01,9.03,8]pentadecane-2,4-dicarboxylate
|
|
SMILES |
C[C@@]12CCC[C@@]([C@H]1[C@@H]([C@]34[C@H]2CC[C@H](C3)C(=C)C4)C(=O)[O-])(C)C(=O)[O-]
|
|
InChI |
InChI=1S/C20H28O4/c1-11-9-20-10-12(11)5-6-13(20)18(2)7-4-8-19(3,17(23)24)15(18)14(20)16(21)22/h12-15H,1,4-10H2,2-3H3,(H,21,22)(H,23,24)/p-2/t12-,13+,14-,15+,18+,19-,20+/m1/s1
|
|
InChIKey |
UJFQJDAESQJXTG-UFUZVNNQSA-L
|
|
Synonyms |
gibberellin A12(2-); GA12; C20 skeleton; C20-GA skeleton; C20-gibberellin skeleton; C20-GAs; CHEBI:58627; open lactone gibberrellin skeleton; Q27125924; 1beta,4a-dimethyl-8-methylidene-4aalpha,4bbeta-gibbane-1alpha,10beta-dicarboxylate; (1R,2S,3S,4R,8S,9S,12R)-4,8-dimethyl-13-methylidenetetracyclo[10.2.1.0(1,9).0(3,8)]pentadecane-2,4-dicarboxylate; (1R,2S,3S,4R,8S,9S,12R)-4,8-dimethyl-13-methylidenetetracyclo[10.2.1.01,9.03,8]pentadecane-2,4-dicarboxylate
|
|
CAS | NA | |
PubChem CID | 25244528 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 330.4 | ALogp: | 5.2 |
HBD: | 0 | HBA: | 4 |
Rotatable Bonds: | 0 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 80.3 | Aromatic Rings: | 4 |
Heavy Atoms: | 24 | QED Weighted: | 0.723 |
Caco-2 Permeability: | -5.849 | MDCK Permeability: | 0.00002050 |
Pgp-inhibitor: | 0.003 | Pgp-substrate: | 0.001 |
Human Intestinal Absorption (HIA): | 0.013 | 20% Bioavailability (F20%): | 0.036 |
30% Bioavailability (F30%): | 0.005 |
Blood-Brain-Barrier Penetration (BBB): | 0.775 | Plasma Protein Binding (PPB): | 85.46% |
Volume Distribution (VD): | 0.271 | Fu: | 11.82% |
CYP1A2-inhibitor: | 0.009 | CYP1A2-substrate: | 0.223 |
CYP2C19-inhibitor: | 0.01 | CYP2C19-substrate: | 0.182 |
CYP2C9-inhibitor: | 0.023 | CYP2C9-substrate: | 0.163 |
CYP2D6-inhibitor: | 0.01 | CYP2D6-substrate: | 0.122 |
CYP3A4-inhibitor: | 0.079 | CYP3A4-substrate: | 0.034 |
Clearance (CL): | 0.683 | Half-life (T1/2): | 0.619 |
hERG Blockers: | 0.01 | Human Hepatotoxicity (H-HT): | 0.418 |
Drug-inuced Liver Injury (DILI): | 0.639 | AMES Toxicity: | 0.008 |
Rat Oral Acute Toxicity: | 0.297 | Maximum Recommended Daily Dose: | 0.125 |
Skin Sensitization: | 0.338 | Carcinogencity: | 0.527 |
Eye Corrosion: | 0.68 | Eye Irritation: | 0.592 |
Respiratory Toxicity: | 0.949 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC002559 | 0.773 | D07BSQ | 0.265 | ||||
ENC002555 | 0.613 | D02CJX | 0.261 | ||||
ENC001071 | 0.483 | D0KR5B | 0.259 | ||||
ENC002558 | 0.478 | D0X7HM | 0.257 | ||||
ENC002554 | 0.472 | D0I2SD | 0.255 | ||||
ENC003145 | 0.440 | D0F1UL | 0.252 | ||||
ENC000794 | 0.440 | D0B4RU | 0.252 | ||||
ENC002541 | 0.394 | D0X4RS | 0.252 | ||||
ENC003143 | 0.388 | D0IX6I | 0.248 | ||||
ENC002542 | 0.371 | D0Q6NZ | 0.248 |